Development, Characterization, and Evaluation of PSMA-Targeted Glycol Chitosan Micelles for Prostate Cancer Therapy

Figure 10

In vivo antitumor activity of 5% glucose, DOXHCl, CHGC, PCP-CHGC, DOX-CHGC, and DOX-PCP-CHGC micelles in LNCaP-bearing nude mice: (a) mice tumor volume, (b) images of LNCaP xenograft tumors after treatment on 20th day, and (c) mice body weight changed within 20 days. Arrows represent drug administration. Data represented as mean ± SD (). , , .

(a)

(b)

(c)